Literature DB >> 12014952

5D-QSAR: the key for simulating induced fit?

Angelo Vedani1, Max Dobler.   

Abstract

In this journal we recently reported the development and the validation of a four-dimensional (4D)-QSAR (quantitative structure-activity relationships) concept, allowing for multiple conformation, orientation, and protonation state representation of ligand molecules. While this approach significantly reduces the bias with selecting a bioactive conformer, orientation, or protonation state, it still requires a "sophisticated guess" about manifestation and magnitude of the associated local induced fit-the adaptation of the receptor binding pocket to the individual ligand topology. We have therefore extended our concept (software Quasar) by an additional degree of freedom--the fifth dimension--allowing for a multiple representation of the topology of the quasi-atomistic receptor surrogate. While this entity may be generated using up to six different induced-fit protocols, we demonstrate that the simulated evolution converges to a single model and that 5D-QSAR--due to the fact that model selection may vary throughout the entire simulation--yields less biased results than 4D-QSAR where only a single induced- fit model can be evaluated at a time. Using two bioregulators (the neurokinin-1 receptor and the aryl hydrocarbon receptor), we compare the results obtained with 4D- and 5D-QSAR. The NK-1 receptor system (represented by a total of 65 antagonist molecules) converges at a cross-validated r2 of 0.870 and a predictive r2 of 0.837; the corresponding values for the Ah receptor system (represented by a total of 131 dibenzodioxins, dibenzofurans, biphenyls, and polyaromatic hydrocarbons) are 0.838 and 0.832, respectively. The results indicate that the formal investment of additional computer time is well-returned both in quantitative and in qualitative values: less-biased boundary conditions, healthier (i.e., less inbred) model populations, and more accurate predictions of new compounds.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12014952     DOI: 10.1021/jm011005p

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  21 in total

1.  A comprehensive analysis of the thermodynamic events involved in ligand-receptor binding using CoRIA and its variants.

Authors:  Jitender Verma; Vijay M Khedkar; Arati S Prabhu; Santosh A Khedkar; Alpeshkumar K Malde; Evans C Coutinho
Journal:  J Comput Aided Mol Des       Date:  2008-01-25       Impact factor: 3.686

Review 2.  Computational methods in drug discovery.

Authors:  Gregory Sliwoski; Sandeepkumar Kothiwale; Jens Meiler; Edward W Lowe
Journal:  Pharmacol Rev       Date:  2013-12-31       Impact factor: 25.468

3.  Molecular fingerprint-based artificial neural networks QSAR for ligand biological activity predictions.

Authors:  Kyaw-Zeyar Myint; Lirong Wang; Qin Tong; Xiang-Qun Xie
Journal:  Mol Pharm       Date:  2012-08-31       Impact factor: 4.939

4.  Computational ligand-based rational design: Role of conformational sampling and force fields in model development.

Authors:  Jihyun Shim; Alexander D Mackerell
Journal:  Medchemcomm       Date:  2011-05       Impact factor: 3.597

5.  Meta-heuristics on quantitative structure-activity relationships: study on polychlorinated biphenyls.

Authors:  Lorentz Jäntschi; Sorana D Bolboacă; Radu E Sestraş
Journal:  J Mol Model       Date:  2009-07-17       Impact factor: 1.810

Review 6.  Recent advances in fragment-based QSAR and multi-dimensional QSAR methods.

Authors:  Kyaw Zeyar Myint; Xiang-Qun Xie
Journal:  Int J Mol Sci       Date:  2010-10-08       Impact factor: 5.923

7.  In Silico Design and Evaluation of Carboxylesterase Inhibitors.

Authors:  Shana V Stoddard; Xiaozhen Yu; Philip M Potter; Randy M Wadkins
Journal:  J Pest Sci (2004)       Date:  2010       Impact factor: 5.918

8.  Improved, selective, human intestinal carboxylesterase inhibitors designed to modulate 7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecin (Irinotecan; CPT-11) toxicity.

Authors:  Latorya D Hicks; Janice L Hyatt; Shana Stoddard; Lyudmila Tsurkan; Carol C Edwards; Randy M Wadkins; Philip M Potter
Journal:  J Med Chem       Date:  2009-06-25       Impact factor: 7.446

9.  Analysis of the inhibition of mammalian carboxylesterases by novel fluorobenzoins and fluorobenzils.

Authors:  Latorya D Hicks; Janice L Hyatt; Teri Moak; Carol C Edwards; Lyudmila Tsurkan; Monika Wierdl; Antonio M Ferreira; Randy M Wadkins; Philip M Potter
Journal:  Bioorg Med Chem       Date:  2007-03-12       Impact factor: 3.641

10.  3D-QSAR and docking studies on 4-anilinoquinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors.

Authors:  Haregewein Assefa; Shantaram Kamath; John K Buolamwini
Journal:  J Comput Aided Mol Des       Date:  2003-08       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.